Publication Information

{'id': 'https://openalex.org/W1994031138', 'doi': 'https://doi.org/10.1158/1538-7445.am2011-5369', 'title': 'Abstract 5369: Prostate cancer radiosensitization through PARP-1 hyperactivation', 'display_name': 'Abstract 5369: Prostate cancer radiosensitization through PARP-1 hyperactivation', 'publication_year': 2011, 'publication_date': '2011-04-01', 'ids': {'openalex': 'https://openalex.org/W1994031138', 'doi': 'https://doi.org/10.1158/1538-7445.am2011-5369', 'mag': '1994031138'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2011-5369', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5101978532', 'display_name': 'Ying Dong', 'orcid': 'https://orcid.org/0000-0003-4135-932X'}, 'institutions': [{'id': 'https://openalex.org/I867280407', 'display_name': 'The University of Texas Southwestern Medical Center', 'ror': 'https://ror.org/05byvp690', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I867280407']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Ying Dong', 'raw_affiliation_strings': ['1University of Texas Southwestern Medical Center at Dallas, Dallas, TX.'], 'affiliations': [{'raw_affiliation_string': '1University of Texas Southwestern Medical Center at Dallas, Dallas, TX.', 'institution_ids': ['https://openalex.org/I867280407']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5033059710', 'display_name': 'Erik A. Bey', 'orcid': 'https://orcid.org/0000-0003-2951-1480'}, 'institutions': [{'id': 'https://openalex.org/I867280407', 'display_name': 'The University of Texas Southwestern Medical Center', 'ror': 'https://ror.org/05byvp690', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I867280407']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Erik A. Bey', 'raw_affiliation_strings': ['1University of Texas Southwestern Medical Center at Dallas, Dallas, TX.'], 'affiliations': [{'raw_affiliation_string': '1University of Texas Southwestern Medical Center at Dallas, Dallas, TX.', 'institution_ids': ['https://openalex.org/I867280407']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5061259992', 'display_name': 'Longshan Li', 'orcid': 'https://orcid.org/0009-0004-4439-6833'}, 'institutions': [{'id': 'https://openalex.org/I867280407', 'display_name': 'The University of Texas Southwestern Medical Center', 'ror': 'https://ror.org/05byvp690', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I867280407']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Longshan Li', 'raw_affiliation_strings': ['1University of Texas Southwestern Medical Center at Dallas, Dallas, TX.'], 'affiliations': [{'raw_affiliation_string': '1University of Texas Southwestern Medical Center at Dallas, Dallas, TX.', 'institution_ids': ['https://openalex.org/I867280407']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5016606481', 'display_name': 'David A. Boothman', 'orcid': 'https://orcid.org/0000-0001-7474-9020'}, 'institutions': [{'id': 'https://openalex.org/I867280407', 'display_name': 'The University of Texas Southwestern Medical Center', 'ror': 'https://ror.org/05byvp690', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I867280407']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'David A. Boothman', 'raw_affiliation_strings': ['1University of Texas Southwestern Medical Center at Dallas, Dallas, TX.'], 'affiliations': [{'raw_affiliation_string': '1University of Texas Southwestern Medical Center at Dallas, Dallas, TX.', 'institution_ids': ['https://openalex.org/I867280407']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 65}, 'biblio': {'volume': '71', 'issue': '8_Supplement', 'first_page': '5369', 'last_page': '5369'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12356', 'display_name': 'Bioactive Compounds and Antitumor Agents', 'score': 0.9953, 'subfield': {'id': 'https://openalex.org/subfields/3005', 'display_name': 'Toxicology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12356', 'display_name': 'Bioactive Compounds and Antitumor Agents', 'score': 0.9953, 'subfield': {'id': 'https://openalex.org/subfields/3005', 'display_name': 'Toxicology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11845', 'display_name': 'Cancer therapeutics and mechanisms', 'score': 0.9722, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11914', 'display_name': 'PARP inhibition in cancer therapy', 'score': 0.9721, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/radiosensitizer', 'display_name': 'Radiosensitizer', 'score': 0.85113287}, {'id': 'https://openalex.org/keywords/parp-inhibitor', 'display_name': 'PARP inhibitor', 'score': 0.59789497}, {'id': 'https://openalex.org/keywords/hyperactivation', 'display_name': 'Hyperactivation', 'score': 0.47895342}, {'id': 'https://openalex.org/keywords/parp1', 'display_name': 'PARP1', 'score': 0.47083592}, {'id': 'https://openalex.org/keywords/olaparib', 'display_name': 'Olaparib', 'score': 0.469487}], 'concepts': [{'id': 'https://openalex.org/C2776428644', 'wikidata': 'https://www.wikidata.org/wiki/Q2126468', 'display_name': 'Radiosensitizer', 'level': 3, 'score': 0.85113287}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.7392164}, {'id': 'https://openalex.org/C2780192828', 'wikidata': 'https://www.wikidata.org/wiki/Q181257', 'display_name': 'Prostate cancer', 'level': 3, 'score': 0.6673317}, {'id': 'https://openalex.org/C182979987', 'wikidata': 'https://www.wikidata.org/wiki/Q3907241', 'display_name': 'Poly ADP ribose polymerase', 'level': 4, 'score': 0.61945826}, {'id': 'https://openalex.org/C2779138821', 'wikidata': 'https://www.wikidata.org/wiki/Q7118227', 'display_name': 'PARP inhibitor', 'level': 5, 'score': 0.59789497}, {'id': 'https://openalex.org/C75520062', 'wikidata': 'https://www.wikidata.org/wiki/Q15321392', 'display_name': 'NAD+ kinase', 'level': 3, 'score': 0.5911363}, {'id': 'https://openalex.org/C2779723316', 'wikidata': 'https://www.wikidata.org/wiki/Q6459234', 'display_name': 'LNCaP', 'level': 4, 'score': 0.51282173}, {'id': 'https://openalex.org/C31573885', 'wikidata': 'https://www.wikidata.org/wiki/Q304484', 'display_name': 'Programmed cell death', 'level': 3, 'score': 0.48896444}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.48512042}, {'id': 'https://openalex.org/C2778366672', 'wikidata': 'https://www.wikidata.org/wiki/Q5957687', 'display_name': 'Hyperactivation', 'level': 2, 'score': 0.47895342}, {'id': 'https://openalex.org/C2776235491', 'wikidata': 'https://www.wikidata.org/wiki/Q9625', 'display_name': 'Prostate', 'level': 3, 'score': 0.47509754}, {'id': 'https://openalex.org/C2778480876', 'wikidata': 'https://www.wikidata.org/wiki/Q21112674', 'display_name': 'PARP1', 'level': 5, 'score': 0.47083592}, {'id': 'https://openalex.org/C2779962180', 'wikidata': 'https://www.wikidata.org/wiki/Q7083106', 'display_name': 'Olaparib', 'level': 5, 'score': 0.469487}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.4471611}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.43879062}, {'id': 'https://openalex.org/C134935766', 'wikidata': 'https://www.wikidata.org/wiki/Q210538', 'display_name': 'DNA repair', 'level': 3, 'score': 0.41634724}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.3863234}, {'id': 'https://openalex.org/C190283241', 'wikidata': 'https://www.wikidata.org/wiki/Q14599311', 'display_name': 'Apoptosis', 'level': 2, 'score': 0.35718688}, {'id': 'https://openalex.org/C509974204', 'wikidata': 'https://www.wikidata.org/wiki/Q180507', 'display_name': 'Radiation therapy', 'level': 2, 'score': 0.29926497}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.2408011}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.1792461}, {'id': 'https://openalex.org/C181199279', 'wikidata': 'https://www.wikidata.org/wiki/Q8047', 'display_name': 'Enzyme', 'level': 2, 'score': 0.09259009}, {'id': 'https://openalex.org/C552990157', 'wikidata': 'https://www.wikidata.org/wiki/Q7430', 'display_name': 'DNA', 'level': 2, 'score': 0.064026386}, {'id': 'https://openalex.org/C82381507', 'wikidata': 'https://www.wikidata.org/wiki/Q416878', 'display_name': 'Polymerase', 'level': 3, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2011-5369', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.64, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4362490467', 'https://openalex.org/W4296617455', 'https://openalex.org/W4281712344', 'https://openalex.org/W4229451438', 'https://openalex.org/W3216411852', 'https://openalex.org/W3135348276', 'https://openalex.org/W3107459115', 'https://openalex.org/W2807317098', 'https://openalex.org/W2551467517', 'https://openalex.org/W2283134145'], 'abstract_inverted_index': {'Abstract': [0], 'The': [1], 'clinical': [2, 33, 193], 'experimental': [3], 'agent,': [4], 'beta-lapachone': [5, 30, 79, 131, 152, 177, 196], '(Arq': [6], '501),': [7], 'can': [8], 'act': [9], 'as': [10, 35, 198], 'a': [11, 36, 51, 145, 190, 199, 208, 241], 'potent': [12], 'radiosensitizer': [13, 200], 'in': [14, 164, 183, 201, 248], 'vitro': [15], 'through': [16], 'an': [17], 'unknown': [18], 'mechanism.': [19], 'In': [20, 73, 144], 'this': [21, 237], 'study,': [22], 'we': [23], 'analyzed': [24], 'the': [25, 135, 140, 280, 285], 'mechanism': [26], 'to': [27, 156, 172, 213, 269], 'determine': [28], 'whether': [29], 'may': [31], 'warrant': [32], 'evaluation': [34], 'radiosensitizer.': [37], 'Beta-lapachone': [38], 'killed': [39], 'prostate': [40, 82, 150, 168, 202], 'cancer': [41, 83, 257], 'cells': [42], 'by': [43, 130, 134, 263], 'NAD(P)H:quinone': [44], 'oxidoreductase': [45], '1': [46], '(NQO1)': [47], 'metabolic': [48], 'bioactivation,': [49], 'triggering': [50], 'massive': [52], 'induction': [53, 123], 'of': [54, 90, 97, 102, 114, 124, 149, 166, 195, 279, 284], 'reactive': [55], 'oxygen': [56], 'species': [57], '(ROS),': [58], 'irreversible': [59], 'DNA': [60, 252], 'single': [61], 'strand': [62], 'breaks': [63], '(SSBs),': [64], 'PARP-1': [65, 141, 215], 'hyperactivation,': [66], 'NAD+/ATP': [67], 'depletion,': [68], 'and': [69, 112, 122, 234, 247], 'µ-calpain-induced': [70, 125], 'programmed': [71, 126], 'necrosis.': [72], 'combination': [74, 184, 249], 'with': [75, 119, 154, 185, 250], 'ionizing': [76], 'radiation': [77], '(IR),': [78], 'radiosensitized': [80], 'NQO1+': [81], 'cells,': [84], 'under': [85], 'conditions': [86], 'where': [87, 176], 'nontoxic': [88], 'doses': [89], 'either': [91], 'agent': [92], 'alone': [93, 181], 'achieved': [94], 'threshold': [95], 'levels': [96, 161], 'SSBs': [98], 'required': [99], 'for': [100, 192, 223, 244, 256, 288], 'hyperactivation': [101], 'PARP-1.': [103], 'Combination': [104], 'therapy': [105], 'significantly': [106], 'elevated': [107, 163], 'SSBs,': [108], 'gamma-H2AX': [109], 'foci': [110], 'formation,': [111], 'poly(ADP-ribosylation)': [113], 'PARP-1,': [115], 'which': [116], 'were': [117, 162], 'associated': [118], 'ATP': [120], 'loss': [121], 'cell': [127, 231], 'death.': [128], 'Radiosensitization': [129], 'was': [132, 261], 'blocked': [133], 'NQO1': [136, 160, 225], 'inhibitor,': [137, 142], 'dicoumarol,': [138], 'or': [139, 182], 'DPQ.': [143], 'mouse': [146], 'xenograft': [147], 'model': [148], 'cancer,': [151, 236], 'synergized': [153], 'IR': [155], 'promote': [157], 'antitumor': [158], 'efficacy.': [159], '∼60%': [165], 'human': [167], 'tumors': [169], 'evaluated': [170], 'relative': [171], 'adjacent': [173], 'normal': [174], 'tissue,': [175], 'might': [178], 'be': [179], 'efficacious': [180], 'radiation.': [186], 'Our': [187], 'findings': [188], 'offer': [189], 'rationale': [191], 'assessment': [194], '(Arq501)': [197], 'cancers': [203, 246], 'that': [204], 'overexpress': [205], 'NQO1,': [206], 'offering': [207], 'potentially': [209], 'synergistic': [210], 'targeting': [211], 'strategy': [212, 238], 'exploit': [214], 'hyperactivation.': [216], 'Since': [217], 'similar': [218], 'data': [219], 'have': [220, 240], 'been': [221], 'found': [222], 'all': [224], 'endogenously': [226], 'over-expressing': [227], 'cancers,': [228], 'including': [229], 'nonsmall': [230], 'lung,': [232], 'pancreatic': [233], 'breast': [235], 'should': [239], 'broad': [242], 'use': [243], 'many': [245, 251], 'damaging': [253], 'agents': [254], 'used': [255], 'therapy.': [258], 'This': [259], 'work': [260], 'supported': [262], 'NIH': [264], 'grant': [265], '2': [266], 'R01': [267], 'CA102792': [268], 'DAB': [270], 'Citation': [271], 'Format:': [272], '{Authors}.': [273], '{Abstract': [274], 'title}': [275], '[abstract].': [276], 'In:': [277], 'Proceedings': [278], '102nd': [281], 'Annual': [282], 'Meeting': [283], 'American': [286], 'Association': [287], 'Cancer': [289, 299], 'Research;': [290], '2011': [291], 'Apr': [292], '2-6;': [293], 'Orlando,': [294], 'FL.': [295], 'Philadelphia': [296], '(PA):': [297], 'AACR;': [298], 'Res': [300], '2011;71(8': [301], 'Suppl):Abstract': [302], 'nr': [303], '5369.': [304], 'doi:10.1158/1538-7445.AM2011-5369': [305]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1994031138', 'counts_by_year': [], 'updated_date': '2024-12-08T13:14:46.211248', 'created_date': '2016-06-24'}